Certara, a leader in model-informed drug development, will participate in the Stephens Annual Investment Conference on November 21, 2024, at 10:00 AM CT. The company’s management will present, and interested parties can access a live webcast through Certara’s investor relations website at https://ir.certara.com. The recording of the presentation will be available for replay for at least 90 days post-event. Certara aims to enhance drug discovery and development using biosimulation technology, serving over 2,400 clients worldwide, including biopharmaceutical companies and regulatory agencies.